Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, College of Medicine Dentistry and Nursing, University of Dundee, Dundee, UK.
Cell Mol Life Sci. 2013 Apr;70(8):1357-80. doi: 10.1007/s00018-012-1134-y. Epub 2012 Sep 7.
In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of active transport at the myocyte cell surface, and its activity is essential for maintaining the trans-sarcolemmal sodium gradient that drives ion exchange and transport processes that are critical for cardiac function. The 72-residue phosphoprotein phospholemman regulates the sodium pump in the heart: unphosphorylated phospholemman inhibits the pump, and phospholemman phosphorylation increases pump activity. Phospholemman is subject to a remarkable plethora of post-translational modifications for such a small protein: the combination of three phosphorylation sites, two palmitoylation sites, and one glutathionylation site means that phospholemman integrates multiple signaling events to control the cardiac sodium pump. Since misregulation of cytosolic sodium contributes to contractile and metabolic dysfunction during cardiac failure, a complete understanding of the mechanisms that control the cardiac sodium pump is vital. This review explores our current understanding of these mechanisms.
在心肌中,肌膜钠/钾 ATP 酶是心肌细胞表面主动转运的主要定量手段,其活性对于维持跨肌膜钠梯度至关重要,该梯度驱动离子交换和运输过程,对心脏功能至关重要。72 个氨基酸残基的磷蛋白磷酸酶调节心脏中的钠泵:未磷酸化的磷酸酶抑制泵,而磷酸酶磷酸化增加泵活性。对于这么小的蛋白质,磷酸酶受到多种翻译后修饰的显著调控:三个磷酸化位点、两个棕榈酰化位点和一个谷胱甘肽化位点的组合意味着磷酸酶整合了多种信号事件来控制心脏钠泵。由于细胞溶质钠的调节失常导致心力衰竭期间的收缩和代谢功能障碍,因此完全了解控制心脏钠泵的机制至关重要。这篇综述探讨了我们对这些机制的当前理解。